Clinical Trials
Clinical trials should be every patient's starting point when it comes to pancreatic cancer. Find out about trials that are available today, and the cutting-edge research available to patients.
150 Articles

Standard of Care Plus
Dr. Allyson Ocean explains why pancreatic cancer patients should consider clinical trials, which go beyond standard of care.

Testing a Breast Cancer Drug for Other Advanced Solid Tumors
In a clinical trial, a new class of breast cancer drug called a kinase inhibitor is being tested to treat pancreatic cancer.

Novel Drug Combination Plus Radiation for Locally Advanced Pancreatic Cancer
A clinical trial combines immunotherapy, common treatments, an antiretroviral drug, and SBRT for locally advanced pancreatic cancer.

Investigating a Drug Used for Other Cancers
In a clinical trial, researchers are adding the drug decitabine to gemcitabine, for patients with advanced cancer that is not responding to treatment.

Chemotherapy, Immunotherapy, and Radiation for Locally Advanced Pancreatic Cancer
A clinical trial combines chemotherapy, immunotherapy, including a pancreas vaccine, and SBRT to stop locally advanced pancreatic cancer.

More Effective Focused Radiation Therapy and Chemotherapy for Locally Advanced Pancreatic Cancer
A clinical trial tests whether adding Zometa makes chemotherapy and stereotactic body radiation therapy (SBRT) more effective against pancreatic cancer.

Presurgical Treatment for Pancreatic Cancer That Is Removable
A clinical trial looks at immunotherapy plus vitamin D plus standard chemotherapy before surgery to remove pancreatic cancer.

Trying a New Type of Treatment to Stop Advanced Pancreatic Cancer
Researchers test the chemotherapy combination of AM0010 and FOLFOX as a second-line therapy for people with metastatic pancreatic cancer.

Testing the Safety of a New Chemotherapy and Radiation Combination
A clinical trial tests the effectiveness of adding PEGPH20 to standard chemotherapy and radiation in patients with locally advanced pancreatic cancer.

Adding a New Drug to Standard Treatment for Metastatic Pancreatic Cancer
A clinical trial tests the effectiveness of napabucasin, a drug that affects the signaling pathways of cancer stem cells.

Testing a Signal-Inhibiting Drug on Tumors with Specific Mutations
A new drug for certain tumor mutations is being tested in a type of clinical trial called a basket trial, which matches tumor genetics and drugs.

Comparing Chemotherapy and Radiation Regimens to Prevent Recurrence of Pancreatic Cancer
A clinical trial compares standard chemotherapy with gemcitabine to the combination of chemotherapy with capecitabine and radiation.

Using a Virus to Infect and Destroy Pancreatic Cancer Cells
A clinical trial tests the combination of standard chemotherapy plus a common cold virus that has been modified to kill cancer cells.

Testing Standard Treatment Plus an Antibody to Shrink Pancreatic Tumors
Researchers are testing whether adding a monoclonal antibody to standard chemotherapy will make locally advanced pancreatic cancer qualify for surgery.

Electrical Pulses to Destroy Pancreatic Cancer Cells
A clinical trial looks the effectiveness of NanoKnife surgery on pancreatic cancer tumors that cannot be removed by traditional surgery.